About Atlas5D

Tim applies his formal training in electromagnetics and plasma physics to innovations in signal processing, computer vision, and machine learning. Before Atlas5D, he spent six years as a consultant at Exponent, where his areas of expertise included ground-penetrating radar, power transmission, electromagnetic compatibility, root-cause failure analysis and IP litigation. Tim received his PhD in Electrical Engineering from Stanford University. While at Stanford, he was one of 24 Americans to receive the Young Scientist Award from the International Union of Radio Science in 2008. His doctoral thesis examined antenna-plasma interactions aboard near-Earth spacecraft and he is the author of numerous peer-reviewed publications and holds multiple patents.

Julia is Vice President of Strategy and Portfolio Planning at Milestone Pharmaceuticals, and held former leadership positions at Health Advances (Partner), Biogen (Senior Director, Global Market Access and Medical Outcomes Strategy), Amylin, Roche, and RAND. Trained in mathematics and health policy, she has authored publications in health technology assessment for journals such as Nature, Health Services Research, Diabetes Medicine, and Plos Medicine. More information about Julia may be found at milestonepharma.com/about-us/leadership-team.

Scott is a founder of GreyBird Ventures. He’s also been a professor of radiology at Harvard Medical School, a professor in the Department of Health Policy and Management at the Harvard School of Public Health, and he’s both the Founder and Director Emeritus of the MGH Institute for Technology Assessment. He has authored more than 250 scientific articles, published three textbooks and presented numerous papers, lectures, and workshops nationally and internationally. More information about Scott may be found at greybirdventures.com.

Zeb has two decades of experience in medicine and computer science. He most recently spent five years in McKinsey’s Healthcare Technology Practice, serving governments, hospitals, pharmaceutical firms and medical device manufacturers worldwide. Prior to McKinsey, Zeb was a postdoctoral fellow at Harvard Medical School and an early member of the Federal Office of the National Coordinator for Health Information Technology. Zeb has an MD from Northwestern University, an MBA from MIT Sloan, an Master’s Degree in computer science from the University of Illinois at Urbana-Champaign, and a Bachelor of Arts degree in math-physics from Brown University.

Tom is a founder of GreyBird Ventures and the former CEO of the Customer Solutions Division of Siemens Medical, where he was the first non-German CEO of a German factory and business unit. He is widely sought for speaking and advisory roles, including a recent commencement address at the prestigious Indian Institute of Technology. More information about Tom may be found at greybirdventures.com.

Bob is the VP and GM of electronics manufacturer Scanning Devices. Bob was a two-term, Board President of Ethos, a non-profit that serves older and disabled residents of Boston. From 1988 to 2009 he held executive roles at Lifeline Systems, the leader in Personal Response Services. These roles include VP of Marketing, VP of Government Services, and VP and GM for Lifeline’s Consumer Service Division, as well as (following the 2006 acquisition by Philips) VP of Acquisitions/Integration.

Mark is the Accenture Professor of Biomedical Informatics at Vanderbilt University and the former Chief Medical Officer of Express Scripts. He has been active in regional efforts in secure health data exchange and led the Owen School of Management’s Masters of Management in Health Care program. Mark trained as a physician-scientist and manager at Washington University and Stanford and is a member of the Institute of Medicine of the National Academies.

Regi is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School, and author of the best-selling book “Who Killed Health Care?: America’s $2 Trillion Medical Problem – and the Consumer-Driven Cure.” She is a leader in the emerging space of online entrepreneurial education. She regularly posts on her Vimeo channel and offers an HBS course.

Tony is a globally-sought consultant in international marketing. He is the former head of Worldwide Markets for Apple, served as the VP Marketing at AOL and at TiVo; and is the founder of startup, Planstorm. At Apple, he was invited to testify before Congress on U.S. education policy. More information about Tony may be found at tonylee.com.

Sam is the CEO of Vital Matters. Previously Sam was a director as well as a senior partner at McKinsey and Company where he led the business technology practice covering pharmaceutical and medical products. He also co-led McKinsey’s Advanced Data and Analytics practice. Sam coined the term “real-world evidence” (RWE) to describe methods for understanding the effectiveness of treatments in real-world settings.

Ron is the Chief Executive Officer of U.S. Pharmacopeial Convention (USP). Previously, he was a partner in McKinsey and Company’s pharmaceutical practice where he led McKinsey’s global drug safety and regulatory service line. At Biogen Idec he launched the Value-Based Medicine division, which focuses on personalized medicine in motor disorders.

Steve leads the clinical and health management business of a large professional services company. Previously he was a partner at McKinsey and Company, serving life sciences and healthcare companies. Prior, Steve was the lead analyst at Goldman Sachs, covering IT within the health industry and health services companies as a whole, and the co-founder of a clinical software company whose solutions are now used by over 1,000 US hospitals. He has held both board and advisory roles within numerous IT health companies.